Web-based Insulin Titration - An Efficacy Study
Web-based Insulin Titration: Improving Diabetes Care in the Netherlands. An Efficacy Study.
1 other identifier
interventional
73
1 country
1
Brief Summary
The main objective of the study is to determine whether an intensive web-based titration system, called PANDIT (Patient Assisting Net-based Diabetes Insulin Titration), is effective in improving glycaemic control in patients with diabetes mellitus type 2 using a basal insulin, compared to standard care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable diabetes-mellitus-type-2
Started Dec 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 22, 2012
CompletedFirst Posted
Study publicly available on registry
October 26, 2012
CompletedStudy Start
First participant enrolled
December 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2014
CompletedNovember 20, 2014
November 1, 2014
1.5 years
October 22, 2012
November 19, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
Mean change in HbA1c
Change from baseline after 13 weeks and after 26 weeks
Secondary Outcomes (7)
Quality of life and treatment satisfaction
Change from baseline after 13 weeks and after 26 weeks
Total contact time with study staff (and the PANDIT system, if applicable)
After 26 weeks
Proportion of subjects who reach the target of HbA1c < 7.0%
After 26 weeks
Mean change in fasting plasma glucose
Change from baseline after 13 weeks and after 26 weeks
Overall incidence and rate of hypoglycaemia (mild hypoglycaemia, probable hypoglycaemia, severe hypoglycaemia and relative hypoglycaemia)
After 26 weeks
- +2 more secondary outcomes
Study Arms (2)
Web-based insulin titration
EXPERIMENTALAn online web-based insulin titration algorithm to guide patients in self-titration
Standard care
NO INTERVENTIONInterventions
Eligibility Criteria
You may qualify if:
- Male or female between 18 and 80 years
- Type 2 diabetes mellitus (diagnosed clinically) for ≥ 6 months
- Once daily basal insulin therapy usage
- No restriction on HbA1c or FPG
- BMI \< 40 kg/m2
- Ability to read and understand the Dutch language
- Familiarity with the Internet and use of a mobile phone
- Ability and willingness to adhere to the protocol
- Ability and willingness to use a web-based insulin self-titration system
- Confirmed written consent
You may not qualify if:
- Type 1 diabetes
- Use of systemic corticosteroid in the last three months
- Recurrent severe hypoglycaemia or hypoglycaemic unawareness
- Active proliferative diabetic retinopathy
- Any clinically significant disease or disorder
- Mental condition rendering the patient unable to understand the nature, scope and possible consequences of the study
- Working in night shifts
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Academic Medical Center
Amsterdam, Netherlands
Related Publications (3)
Simon AC, Holleman F, Hoekstra JB, De Clercq PA, Lemkes BA, Hermanides J, Peek N. Development of a web-based decision support system for insulin self-titration. Stud Health Technol Inform. 2011;169:103-7.
PMID: 21893723RESULTSimon AC, Holleman F, Gude WT, Hoekstra JB, Peek N. Safety of a web-based insulin titration system for patients with type 2 diabetes mellitus - pilot study. Stud Health Technol Inform. 2012;180:731-5.
PMID: 22874288RESULTGude WT, Simon AC, Peute LW, Holleman F, Hoekstra JB, Peek N, Jaspers MW. Formative usability evaluation of a web-based insulin self-titration system: preliminary results. Stud Health Technol Inform. 2012;180:1209-11.
PMID: 22874403RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Frits Holleman, MD PhD
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD PhD
Study Record Dates
First Submitted
October 22, 2012
First Posted
October 26, 2012
Study Start
December 1, 2012
Primary Completion
June 1, 2014
Study Completion
July 1, 2014
Last Updated
November 20, 2014
Record last verified: 2014-11